Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand

Kositwattanarerk, A.; Changmuang, W.; Sangsuriyan, J.; Thongklam, K.; Sritara, C.; Utamakul, C.; Chamroonrat, W.; Thamnirat, K.; Anongpornyochkul, Y.; Chancharunee, S.

Journal of the Medical Association of Thailand 96(6): 756-760

2013

ISSN/ISBN: 0125-2208
PMID: 23951835
Document Number: 10417
Radioimmunotherapy (RIT) with 131-rituximab is a safe and effective treatment in patients with relapsed, refractory follicular lymphoma. The authors demonstrated the first case of 131-rituximab treatment in the patient with relapsed non-Hodgkin's lymphoma (NHL) in Thailand. There was no immediate complication after treatment. Impressive treatment response occurred.

Document emailed within 1 workday
Secure & encrypted payments

131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand

O'Sullivan, C.C.; Ozdemirli, M.; Bazylewicz, M.; Cheson, B.D. 2013: Complete response to brentuximab vedotin in a transplant-naïve patient with relapsed CD30-positive nodular lymphocyte-predominant Hodgkin lymphoma Clinical Advances in Hematology and Oncology: H&o 11(6): 382-385
Verani, D.A. 1991: Association of non-Hodgkin's lymphoma and Kaposi's sarcoma in a patient with HIV infection: case report Bollettino dell'Istituto Sieroterapico Milanese 70(1-2): 453-455
Albano, D.; Sinagra, E.; Patti, C.; Narese, D.; Agrusa, A.; Di Buono, G.; Raimondo, D.; Midiri, M.; Lagalla, R.; Galia, M. 2017: Caecal leiomyoma detected by whole-body MRI in a patient with Hodgkin lymphoma: first case report Il Giornale di Chirurgia 38(1): 27-32
Chuengsamarn, S. 2005: Hashimoto's thyroiditis in a patient with non-Hodgkin's thyroid lymphoma of B cell type and originated from mucosa-associated lymphoid tissue (MALT): A case report Journal of the Medical Association of Thailand 88 Suppl. 1: S73-S78
Sarris, A.H.; Romaguera, J.; Hagemeister, F.B.; Rodriguez, M.A.; McLaughlin, P.; Pro, B.; Younes, A.; Mesina, O.; Cabanillas, F.; Medeiros, L.J.; Samuels, B. 2001: Irinotecan in relapsed or refractory non-Hodgkin's lymphoma Oncology 15(7 Suppl. 8): 53-56
Davidson, K.L.; Devaney, M.B.; Tighe, J.E.; Rogers, S.Y.; Dunlop, D.J.; Mackie, M.J.; Thomas, R.V.; Johnson, P.R.E. 2003: A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study Haematologica 88(12): 1366-1371
Stiff, P.J. 1998: Blood and marrow transplantation in relapsed or refractory non-Hodgkin's lymphoma Oncology 12(10 Suppl 8: 56-62
Kim, T-Kyun.; Wajima, D.; Yonezawa, T.; Takamura, Y.; Miyamae, S. 2014: Intra-tumoral hemorrhage of a relapsed CNS diffuse large B-cell lymphoma: a case report No Shinkei Geka. Neurological Surgery 42(7): 651-658
Nishimori, H.; Fujii, N.; Maeda, Y.; Matsuoka, K.-I.; Takenaka, K.; Shinagawa, K.; Ikeda, K.; Matsuo, K.; Harada, M.; Tanimoto, M. 2009: Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma Anticancer Research 29(5): 1749-1754
Tachi, T.; Yasuda, M.; Usui, K.; Umeda, M.; Nagaya, K.; Osawa, T.; Ichihashi, A.; Noguchi, Y.; Goto, H.; Kasahara, S.; Takahashi, T.; Goto, C.; Teramachi, H. 2015: Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma Die Pharmazie 70(10): 674-677
Naparstek, E. 2005: The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma Current Hematology Reports 4(4): 276-283
Herold, M.; Sacchi, S.; Hieke, K. 2002: The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use Haematologica 87(7): 719
Zinzani, P.L.; Martelli, M.; Tura, S.; Mandelli, F. 1993: Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma Haematologica 78(1): 40-43
Williams, M.E. 2004: ECOG 4402: randomized phase III-trial comparing two different rituximab dosing regimens for patients with low tumor burden indolent non-Hodgkin's lymphoma Current Hematology Reports 3(6): 395-396
Fukushima, H.; Inoue, T.; Ishi, N.; Okuno, T.; Son, R.; Soejima, C.; Horiuchi, M.; Ueda, H.; Yoshida, M.; Hagihara, K.; Kanashima, H.; Nakao, T.; Yamane, T. 2015: Peripheral T-Cell Lymphoma, not Otherwise Specified Occurring After the Treatment of Relapsed Follicular Lymphoma Rinsho Byori. Japanese Journal of Clinical Pathology 63(9): 1029-1034
Morales, E.; Bancalari, G.; Fahrenkrog, A.M.; Rossle, A. 1999: Chronic myeloid leukemia and non Hodgkin lymphoma in the same patient. Clinical case Revista Medica de Chile 127(9): 1105-1107
De Giorgi, S.; Piazzolla, A.; De Giorgi, G.; Cimmino, A.; Parisi, G.; Ricco, R. 2004: Non-Hodgkin's lymphoma in the gluteal region: a case report La Chirurgia Degli Organi di Movimento 89(4): 329-338
Anuradha; Sinha, A.; Ramrakhiani, D. 2005: Primary non-Hodgkin's lymphoma of the breast: a case report Acta Cytologica 49(6): 661-665
Guven, S.; Ozcebe, O.I.; Tuncer, Z.S. 2005: Non-Hodgkin's lymphoma complicating pregnancy: a case report European Journal of Gynaecological Oncology 26(4): 457-458
Rozanković, S.; Iveković, R.; Novak-Laus, K.; Talan-Hranilović, J.; Broz, R.; Mandić, Z. 2006: Primary non-Hodgkin orbital lymphoma: case report Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 60(2): 175-180